Food & BeveragesJul 17, 2026

Taisho Pharmaceutical Holdings Co., Ltd

Company Profile Analysis

Book Demo Subscribe Now

Taisho Pharmaceutical Holdings Co., Ltd - Food & Beverages showcase

Year Founded & Workforce

1911-12-31

9,134 Employees

Industry

Food & Beverages

Services

Taisho Pharmaceutical Holdings Co., Ltd Overview

Company Headquarters: Tokyo, Japan

Founded: 1912

Workforce: ~9,134

Company Working: Taisho Pharmaceutical Holdings Co. Ltd. is a pharmaceutical which is engaged in the research and development, manufacturing, and sale over the counter drugs, quasi-drugs, foods, medical supplies, hygiene products, and ethical drugs. The company operates its business mainly tow segment such as self-medical segment and the pharmaceutical segment. In addition, the self-medication segment includes the research, development, manufacture, and sale of over-the-counter drugs, quasi-drugs, foods, medical supplies, and hygiene products. The pharmaceutical segment includes the research, development, manufacture, and sale of ethical drugs. The company has strong business operation in North America, Europe, Asia-Pacific, and Rest of the World.

Strategy

Taisho Pharmaceutical Holdings is a Japanese company primarily engaged in the development, manufacture, and sale of pharmaceutical products. Taisho Pharmaceutical Holdings was focused on expanding its global presence by increasing its presence in emerging markets and developing new products for global markets. They had acquired several companies in recent years, including UPSA in France and Bristol-Myers Squibb's consumer health business in Japan, which had helped to expand their product portfolio and increase their global reach. Taisho Pharmaceutical Holdings aimed to increase sales of their core products, such as Lipovitan D (an energy drink) and Pabron (a cold medicine), by leveraging their strong brand recognition in Japan and expanding distribution channels. Investing in research and development: The company invested a significant portion of their budget into research and development, with the goal of developing new drugs and products that would address unmet medical needs. Taisho Pharmaceutical Holdings had committed to reducing their environmental impact and promoting sustainable practices across their business operations, such as reducing waste and increasing energy efficiency.

Company Snapshot

$2,654.9M

Revenue

9,134

Employees

1911-12-31

Founded

Tokyo, Japan

Headquarters

SWOT Analysis

Strengths

Brand Portfolio
Financial Performance
Manufacturing Capabilities

Weaknesses

Dependence on the Japanese market
Limited presence in international markets

Opportunities

Growing demand for healthcare products and services
Increasing focus on research and development of innovative healthcare products

Threats

Intense Competition
Regulatory hurdles and pricing pressures
Foreign Exchange Risks

Key Developments

Date	Approach	Development
Apr 2020	Product launch	Japan’s Taisho Pharmaceutical Holdings has released Japan’s first caffeine-free energy drink containing the botanical ingredient, enXtra, which has been clinically proven to improve alertness and focus up to five hours with or without caffeine.

Product Offering

Taisho Pharmaceutical Holdings Co., Ltd
- PreRiUP L
- Nanobody

Financial Performance

A plan for every need

Forecast+

Get unlimited access to forecasts, charts, and company data across every research report on Wantstats.

USD200/mo

About the Author

Wantstats Research Team

Wantstats' research desk profiles Taisho Pharmaceutical Holdings Co., Ltd as part of our ongoing coverage of the Food & Beverages sector, drawing on public company data, filings, and market intelligence.

Powering the world's best teams.
From next-gen startups to established enterprises.

See our work in action

Start your data driven journey with us!

Book a Demo Now

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Taisho Pharmaceutical Holdings Co., Ltd

Company Headquarters: Tokyo, Japan Founded: 1912 Workforce: ~9,134 Company Working: Taisho Pharmaceutical Holdings Co. Ltd. is a pharmaceutical which is engaged in the research and development, manufacturing, and sale over the counter drugs, quasi-drugs, foods, medical supplies, hygiene products, and ethical drugs. The company operates its business mainly tow segment such as self-medical segment and the pharmaceutical segment. In addition, the self-medication segment includes the research, development, manufacture, and sale of over-the-counter drugs, quasi-drugs, foods, medical supplies, and hygiene products. The pharmaceutical segment includes the research, development, manufacture, and sale of ethical drugs. The company has strong business operation in North America, Europe, Asia-Pacific, and Rest of the World.

Starting from

$4,950